presented by william tap at 2014 asco annual meeting

23
<br /> A Pilot Study of PLX3397, a Selective Colony-Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitor, in Pigmented Villonodular Synovitis (PVNS) Presented By William Tap at 2014 ASCO Annual Meeting

Upload: noreen

Post on 23-Feb-2016

46 views

Category:

Documents


0 download

DESCRIPTION

A Pilot Study of PLX3397, a Selective Colony-Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitor, in Pigmented Villonodular Synovitis (PVNS) . Presented By William Tap at 2014 ASCO Annual Meeting. Pigmented Villonodular Synovitis (PVNS)Tenosynovial Giant Cell Tumor (TGCT). - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Presented By William Tap at 2014 ASCO Annual Meeting

<br /> A Pilot Study of PLX3397, a Selective Colony-Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitor, in Pigmented Villonodular Synovitis (PVNS)

Presented By William Tap at 2014 ASCO Annual Meeting

Page 2: Presented By William Tap at 2014 ASCO Annual Meeting

Pigmented Villonodular Synovitis (PVNS)<br />Tenosynovial Giant Cell Tumor (TGCT)

Presented By William Tap at 2014 ASCO Annual Meeting

Page 3: Presented By William Tap at 2014 ASCO Annual Meeting

Pigmented Villonodular Synovitis (PVNS)

Presented By William Tap at 2014 ASCO Annual Meeting

Page 4: Presented By William Tap at 2014 ASCO Annual Meeting

Slide 4

Presented By William Tap at 2014 ASCO Annual Meeting

Page 5: Presented By William Tap at 2014 ASCO Annual Meeting

Can we help patients (PVNS) <br />with a highly targeted therapy (PLX3397)<br />that blocks the CSF1R pathway <br />in this clonal neoplastic process frequently<br />initiated by a single genetic event?

Presented By William Tap at 2014 ASCO Annual Meeting

Page 6: Presented By William Tap at 2014 ASCO Annual Meeting

Study Goals

Presented By William Tap at 2014 ASCO Annual Meeting

Page 7: Presented By William Tap at 2014 ASCO Annual Meeting

Study Design

Presented By William Tap at 2014 ASCO Annual Meeting

Page 8: Presented By William Tap at 2014 ASCO Annual Meeting

Efficacy Assessments

Presented By William Tap at 2014 ASCO Annual Meeting

Page 9: Presented By William Tap at 2014 ASCO Annual Meeting

Tumor Volume Score (TVS)

Presented By William Tap at 2014 ASCO Annual Meeting

Page 10: Presented By William Tap at 2014 ASCO Annual Meeting

Patient Disposition

Presented By William Tap at 2014 ASCO Annual Meeting

Page 11: Presented By William Tap at 2014 ASCO Annual Meeting

Patient Characteristics: Safety Population (n=23)

Presented By William Tap at 2014 ASCO Annual Meeting

Page 12: Presented By William Tap at 2014 ASCO Annual Meeting

Safety: PVNS Expansion Cohort AEs<br />n = 23 Safety Population

Presented By William Tap at 2014 ASCO Annual Meeting

Page 13: Presented By William Tap at 2014 ASCO Annual Meeting

Treatment-Related AEs ≥ Grade 3

Presented By William Tap at 2014 ASCO Annual Meeting

Page 14: Presented By William Tap at 2014 ASCO Annual Meeting

Duration of Treatment (DOT), April 2014 data cutoff:<br />Median 256 days (range 21-585 days)

Presented By William Tap at 2014 ASCO Annual Meeting

Page 15: Presented By William Tap at 2014 ASCO Annual Meeting

14 patients evaluable with TVS

Presented By William Tap at 2014 ASCO Annual Meeting

Page 16: Presented By William Tap at 2014 ASCO Annual Meeting

Slide 16

Presented By William Tap at 2014 ASCO Annual Meeting

Page 17: Presented By William Tap at 2014 ASCO Annual Meeting

Slide 17

Presented By William Tap at 2014 ASCO Annual Meeting

Page 18: Presented By William Tap at 2014 ASCO Annual Meeting

Slide 18

Presented By William Tap at 2014 ASCO Annual Meeting

Page 19: Presented By William Tap at 2014 ASCO Annual Meeting

Slide 19

Presented By William Tap at 2014 ASCO Annual Meeting

Page 20: Presented By William Tap at 2014 ASCO Annual Meeting

Slide 20

Presented By William Tap at 2014 ASCO Annual Meeting

Page 21: Presented By William Tap at 2014 ASCO Annual Meeting

Slide 21

Presented By William Tap at 2014 ASCO Annual Meeting

Page 22: Presented By William Tap at 2014 ASCO Annual Meeting

Conclusions

Presented By William Tap at 2014 ASCO Annual Meeting

Page 23: Presented By William Tap at 2014 ASCO Annual Meeting

Thank You

Presented By William Tap at 2014 ASCO Annual Meeting